Skip to content

Homoeopathic treatment of CSOM

To evaluate the effectiveness of Calcarea Group in the management of Chronic Suppurative Otitis Media: An Open Label Prospective Clinical Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080086
Enrollment
30
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H652- Chronic serous otitis media

Interventions

Intervention1: Individualize Calcarea Group Homoeopathic Medicine: Intervention- The Calcarea group will be selected according to the totality of symptoms. Dosage- Medicine will be given in varying po

Sponsors

Tulika
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients both male and female will be included in the study. 2.Cases of patients between 2-50 yrs of age. 3.Patients with clinical symptomatology like otalgia and otorrhea with or without hearing disturbances. 4.Cases with duration of discharge more than six weeks used to make the diagnosis. 5.Patients who are willing to fill consent form. 6.Patient taking no other treatment for CSOM.

Exclusion criteria

Exclusion criteria: 1.Patients who are not willing to give their consent for study and not complying regular follow up. 2.Cases with advanced pathology like Cholesteatoma, epidural abscess, meningitis or which requires major surgical interventions. 3.Pregnant and lactating women. 4.Patients with unstable psychiatric illness or other life-threatening systemic disease.

Design outcomes

Primary

MeasureTime frame
To compare the COMOT-15 score at the baseline and after 6 months of treatment to know the effectiveness of Calcarea group.Timepoint: 12 weeks, 24 weeks

Secondary

MeasureTime frame
The aims to assess the effectiveness of the primary medicine from the Calcarea group in cases of Chronic Suppurative Otitis Media (CSOM) and will assist in the clinical validation of the symptoms associated with the prescribed Calcarea group medicine.Timepoint: 12 weeks, 24 weeks

Countries

India

Contacts

Public ContactDr Anirudh Kumar

State National Homoeopathic Medical College and Hospital

Kumardranirudh@gmail.com8953883449

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026